What Syneron and Candela have effectively done by merging (Syneron will spend $65m on the deal for stock), is place themselves in a position where they can benefit from this new competition by having the funds to buy up small-cap and mid-cap companies.Ĭandela and Syneron will continue to trade under their names. “Management will sit across both companies and a more aggressive view will be taken of not only the company but the market.” They are also reaching savvy consumers in a more direct manner – all of this ensures that market competition will become more populated, and more aggressive in future. All of these companies are helping to pave the way for future players in the market, driving improved standards of safety and effectiveness of the procedures and expanding the non-core physician base of end users. The global aesthetic laser and energy devices market is a highly competitive arena, and on their own, Syneron and Candela are up against other large players such as Cynosure, Lumenis, Palomar Medical and Cutera. The company’s headquarters are in Yokneam Illit, Israel. Syneron, meanwhile, has a presence across North America, Europe, the Asia Pacific region, Israel and others. The company is headquartered in Massachusetts, US and in April 2009 it received registration approval from the Chinese State Food and Drug Administration to market the full line of V beam lasers in the People’s Republic of China. More recently it created the Serenity device, which features its Pneumatic Skin Flattening technology to reduce pain during laser light-based treatments.Ĭandela has about 11 subsidiaries operating in the US, Germany, France, Spain, Portugal, Italy, Japan, Australia and the UK. Since then, its innovations have shaped the industry.Ĭandela produced the first vascular lesion treatment laser for use on children, the first Q-switched alexandrite laser for pigmented lesions and tattoos and the first dynamic cooling device for epidermal protection. In 1970 it started developing new technologies for light-based aesthetic therapies for use by physicians and personal care therapists. “The combination of Syneron and Candela will create a leading medical aesthetic device company.”Ĭandela Corporation started its operations much earlier.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |